Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2618898

IR number 1896655
Words TERNS
Image
Image description BIRD,STYLISED
Status protected: Registered/protected
Priority date 08 Aug 2025 (Convention)
Classes 5, 42
Kind Figurative
Dates
Renewal due 12 Nov 2035
Registration advertised / published 23 Apr 2026
Entered on Register 23 Apr 2026
Acceptance advertised / published 16 Feb 2026
Acceptance 16 Feb 2026
IR notification 15 Jan 2026
Filing 12 Nov 2025
Registered from 12 Nov 2025

Owner Address for service
Terns Pharmaceuticals, Inc.

IR Contact

Tiffany D. Gehrke Marshall, Gerstein & Borun LLP


Goods & Services
Class 5: Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.
Class 42: Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; research and development services in the field of pharmaceutical and biologic preparations; research and development services in the field of oncology-related diseases and disorders; research and development services in the field of metabolic-related diseases and disorders; research and development services in the field of endocrine-related diseases and disorders; research and development services in the fields of diabetes and obesity-related diseases and disorders; research and development services in the field of peptide pharmaceutical preparations; providing medical and scientific research information in the field of small-molecule drugs; providing medical and scientific research information in the field of clinical trials and post-market trials; providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.

Endorsements

The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.


Convention details
Date 08 Aug 2025
Number 99328453
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image